CLINICAL TRIALS PROFILE FOR LEVALBUTEROL HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for levalbuterol hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00064389 ↗ | Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma | Completed | Sunovion | Phase 3 | 2003-01-01 | The purpose of this study is to evaluate the safety of levalbuterol as compared to racemic albuterol based on the frequencies of adverse events reporting during a 12-month period of chronic dosing of adolescent and adult subjects with asthma. |
NCT00073814 ↗ | Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma | Completed | Sunovion | Phase 3 | 2002-12-01 | Study of Daily Dosing with Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects with Asthma |
NCT00073827 ↗ | Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma | Completed | Sunovion | Phase 3 | 2002-05-01 | The primary purpose of this study was to investigate the efficacy of levalbuterol compared to a placebo and compared to albuterol in the treatment and prevention of bronchoconstriction in adolescent and adult subjects with asthma, with all treatments administered 4 times a day (QID). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for levalbuterol hydrochloride
Condition Name
Clinical Trial Locations for levalbuterol hydrochloride
Trials by Country
Clinical Trial Progress for levalbuterol hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for levalbuterol hydrochloride
Sponsor Name